Anavex Life Sciences
AVXL
#9707
Rank
ยฃ78.85 M
Marketcap
ยฃ0.85
Share price
-4.20%
Change (1 day)
-85.56%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -ยฃ9.63 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ29.85 Million, an increase over its 2024 earnings that were of -ยฃ38.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ9.63 Million-67.74%
2025 -ยฃ29.85 Million-22.43%
2024 -ยฃ38.47 Million14.77%
2023 -ยฃ33.52 Million-17.49%
2022 -ยฃ40.63 Million22.96%
2021 -ยฃ33.04 Million35.36%
2020 -ยฃ24.41 Million12.65%
2019 -ยฃ21.67 Million29.09%
2018 -ยฃ16.79 Million36.33%
2017 -ยฃ12.32 Million17.11%
2016 -ยฃ10.52 Million20.91%
2015 -ยฃ8.7 Million-6.29%
2014 -ยฃ9.28 Million337.28%
2013 -ยฃ2.13 Million
2008 -ยฃ3.93 Million106.01%
2007 -ยฃ1.91 Million8848.98%
2006 -ยฃ0.03 Million-79.99%
2005 -ยฃ0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ4.77 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ4.66 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ0.29 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA